Gene · 8454
Papers4,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment. | J Cancer Prev | 2023 | 38205365 | PubTator, text mining | PubMed |
| A Review of the Research Applications of Centipeda minima. | Molecules | 2023 | 38202691 | PubTator, text mining | PubMed |
| Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers. | Front Immunol | 2023 | 38179042 | PubTator, text mining | PubMed |
| Molecular biology of canine parainfluenza virus V protein and its potential applications in tumor immunotherapy. | Front Microbiol | 2023 | 38173672 | PubTator, text mining | PubMed |
| Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. | Cancers (Basel) | 2023 | 38136262 | PubTator, text mining | PubMed |
| Mouse models of diffuse large B cell lymphoma. | Front Immunol | 2023 | 38124747 | PubTator, text mining | PubMed |
| MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting. | Nat Commun | 2023 | 38102140 | PubTator, text mining | PubMed |
| The potential roles of gossypol as anticancer agent: advances and future directions. | Chin Med | 2023 | 38098026 | PubTator, text mining | PubMed |
| Profiling ubiquitin signalling with UBIMAX reveals DNA damage- and SCFβ-Trcp1-dependent ubiquitylation of the actin-organizing protein Dbn1. | Nat Commun | 2023 | 38097601 | PubTator, text mining | PubMed |
| The Pivotal Role of Nrf2 Signal Axis in Intervertebral Disc Degeneration. | J Inflamm Res | 2023 | 38076332 | PubTator, text mining | PubMed |
| Circadian rhythm-associated lncRNA RP11-414H17.5 as a key therapeutic target in osteosarcoma affects the tumor immune microenvironment and enhances malignancy. | J Orthop Surg Res | 2023 | 38071320 | PubTator, text mining | PubMed |
| FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. | Cancer Res Commun | 2023 | 38032106 | PubTator, text mining | PubMed |
| FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma. | Heliyon | 2023 | 38027627 | PubTator, text mining | PubMed |
| FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. | Front Pharmacol | 2023 | 38027013 | PubTator, text mining | PubMed |
| CCNF (Cyclin F) as a Candidate Gene for Familial Hodgkin Lymphoma: Additional Evidence for the Importance of Mitotic Checkpoint Defects in Tumorigenesis. | Hemasphere | 2023 | 38026792 | PubTator, text mining | PubMed |
| An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancer. | Front Bioinform | 2023 | 38025397 | PubTator, text mining | PubMed |
| Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1. | Viruses | 2023 | 38005838 | PubTator, text mining | PubMed |
| Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation. | Nat Commun | 2023 | 38001062 | PubTator, text mining | PubMed |
| Lysine Demethylase KDM2A Promotes Proteasomal Degradation of TCF/LEF Transcription Factors in a Neddylation-Dependent Manner. | Cells | 2023 | 37998355 | PubTator, text mining | PubMed |
| Selective inhibition of the NLRP3 inflammasome protects against acute ethanol-induced cardiotoxicity in an FBXL2-dependent manner. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37994158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8454/papers?page=11